SCHEMBL20205404

SCHEMBL20205404

Cc1cc(C)cc(-c2cc3c(c4c2oc2ccccc24)-c2cc4c(cc2C3(C)C)-c2c(cc(-c3cc(C)cc(C)c3)c3oc5ccccc5c23)C4(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 2/20 0.36
▸ BRD9 Q9H8M2 1/20 0.35
▸ BRD7 Q9NPI1 1/20 0.35
▸ ALK Q9UM73 2/20 0.33
▸ MAOA P21397 1/20 0.33
▸ CDC14B O60729 1/20 0.32
▸ CDC14A Q9UNH5 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ MAOB P27338 2/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ TNKS O95271 1/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ TNKS2 Q9H2K2 1/20 0.32
▸ PARP2 Q9UGN5 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ TTR P02766 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205446 0.90 PGR (0.36) PGRBRD9BRD7ALKMAOA
SCHEMBL20205335 0.90 CDC14B (0.40) PGRALKCDC14BCDC14AALDH1A1
SCHEMBL20205379 0.89 CDC14B (0.35) PGRALKMAOACDC14BCDC14A
SCHEMBL20205378 0.87 CDC14B (0.38) PGRALKCDC14BCDC14AALDH1A1
SCHEMBL20205637 0.86 ALK (0.34) PGRALKCDC14BCDC14ATNKS
SCHEMBL20205320 0.85 CDC14B (0.37) PGRALKCDC14BCDC14AALDH1A1
SCHEMBL20205333 0.85 PLA2G2A (0.36) PGRALKCDC14BCDC14AALDH1A1
SCHEMBL23351580 0.84 ALOX5 (0.36) PGRALKCDC14BCDC14AHPGD
SCHEMBL20205646 0.84 ALOX5 (0.36) PGRALKCDC14BCDC14A
SCHEMBL20205709 0.84 CDC14B (0.33) PGRALKCDC14BCDC14ATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND PGR 4271/4885BRD9 27/4885BRD7 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback